G. Groth

483 total citations
7 papers, 375 citations indexed

About

G. Groth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, G. Groth has authored 7 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in G. Groth's work include HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer therapeutics and mechanisms (2 papers). G. Groth is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer therapeutics and mechanisms (2 papers). G. Groth collaborates with scholars based in Germany, United Kingdom and Netherlands. G. Groth's co-authors include U. Gatzemeier, Vera Hirsh, Nico van Zandwijk, Claire Barton, Frances A. Shepherd, Charles Butts, Parviz Ghahramani, Andrea Ardizzoni, H Magnussen and Joachim von Pawel and has published in prestigious journals such as Annals of Oncology, European Journal of Cancer and Lung Cancer.

In The Last Decade

G. Groth

7 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Groth Germany	5	279	264	102	73	50	7	375
Michael Zaidinski United States	2	345 1.2×	307 1.2×	132 1.3×	91 1.2×	90 1.8×	5	418
HeeJong Baek South Korea	7	339 1.2×	252 1.0×	47 0.5×	75 1.0×	33 0.7×	11	399
Larry Schlabach United States	8	151 0.5×	185 0.7×	101 1.0×	27 0.4×	27 0.5×	10	300
Penelope Ann Bradbury Canada	9	304 1.1×	227 0.9×	87 0.9×	45 0.6×	116 2.3×	39	375
Petra Hoffknecht Germany	8	581 2.1×	389 1.5×	70 0.7×	65 0.9×	37 0.7×	27	625
Petra Heinmöller Germany	6	136 0.5×	274 1.0×	136 1.3×	95 1.3×	97 1.9×	6	369
Alessandro Gamboni Italy	7	363 1.3×	267 1.0×	103 1.0×	34 0.5×	155 3.1×	12	453
Eric D. Mininberg United States	3	307 1.1×	345 1.3×	192 1.9×	27 0.4×	96 1.9×	6	494
Sara E. Stevens United States	7	168 0.6×	116 0.4×	80 0.8×	29 0.4×	50 1.0×	7	226
J. M. Sanchez Spain	9	315 1.1×	293 1.1×	211 2.1×	29 0.4×	138 2.8×	15	499

Countries citing papers authored by G. Groth

Since Specialization

Citations

This map shows the geographic impact of G. Groth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Groth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Groth more than expected).

Fields of papers citing papers by G. Groth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Groth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Groth. The network helps show where G. Groth may publish in the future.

Co-authorship network of co-authors of G. Groth

This figure shows the co-authorship network connecting the top 25 collaborators of G. Groth. A scholar is included among the top collaborators of G. Groth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Groth. G. Groth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Reck, Martin, et al.. (2004). Tirapazamine, Cisplatin und Gemcitabine beim fortgeschrittenen nichtkleinzelligen Bronchialkarzinom - eine Phase II-Studie. Pneumologie. 58(12). 845–849. 10 indexed citations

2.

Gatzemeier, U., G. Groth, Charles Butts, et al.. (2003). Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer. Annals of Oncology. 15(1). 19–27. 298 indexed citations

3.

Gatzemeier, U., C.J. Twelves, Alan Anthoney, et al.. (2001). A phase I dose-escalation study of zd0473 combined with paclitaxel in refractory solid malignancies. European Journal of Cancer. 37. S74–S75. 5 indexed citations

4.

Gatzemeier, U., G. Groth, Vera Hirsh, et al.. (2001). A randomised phase II study of gemcitabine/cisplatin alone and with herceptin in patients with HER2-positive non-small cell lung cancer (nsclc). European Journal of Cancer. 37. S50–S50. 9 indexed citations

5.

Groth, G., et al.. (2001). A phase II study of LY355703 (cryptophycine) as first-line therapy for stage IIIb or IV NSCLC subjects: preliminary analysis. European Journal of Cancer. 37. S48–S48. 2 indexed citations

6.

Kaye, Stuart, et al.. (2000). An open-label, dose-escalation study of ZD0473 combined with paclitaxel in refractory solid malignancies. Lung Cancer. 29(1). 70–71. 1 indexed citations

7.

Groth, G., et al.. (1991). Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Annals of Oncology. 2(3). 213–215. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact